Drug-specific and developmental heterogeneity in adverse event profiles of atypical antipsychotics in the pediatric population: A FAERS pharmacovigilance study
{{output}}
Objective: To characterize the safety profile of atypical antipsychotics (AAPs) in the pediatric population using the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS), focusing on signal distribution, drug... ...
